Advancing early disease detection and precision medicine with breath-based diagnostics
19 Nov 2024
Billy Boyle, co-founder and CEO of Owlstone Medical, discusses pioneering diagnostics using breath analysis to improve patient outcomes through early disease detection. Owlstone Medical’s proprietary breath biopsy technology employs exogenous probes—targeted compounds inhaled or ingested—to detect disease-specific biomarkers in exhaled breath. This innovative approach aims to save lives and reduce healthcare costs by facilitating early diagnosis and enabling precision medicine in areas like cancer, liver disease, and digestive disease. Collaboration with clinical and academic partners supports further validation and application of this breakthrough technology.
This interview was recorded for #CLINICAL24 2024
About the company
Owlstone Medical
Discover the ReCIVA® Breath Sampler with Owlstone Breath Biopsy® Platform
Breath Biopsy provides reliable non-invasive analysis of biomarkers on breath with applications in early detection and precision medicine. With Breath Biopsy, you can collect and analyze a wide range of volatile organic compounds (VOCs) on breath with wide-ranging relevance for human health..
Our Breath Biopsy Products & Services offer a complete solution for the collection, analysis and discovery of VOC biomarkers in exhaled breath or in vitro samples. Breath Biopsy Products & Services can support clinical and in vitro VOC sample collection and give you the choice of performing your own analysis using TD-GC-MS or FAIMS technologies, or letting our expert team do the work for you at our world-leading Breath Biopsy Laboratory.
ReCIVA® Breath Sampler enables reliable and reproducible, non-invasive Breath Biopsy® sample collection
- Collect volatile organic compound and respiratory droplet samples from exhaled breath
- Simple, non-invasive sampling during normal tidal breathing with options for breath fraction targeting
- Designed and optimized to ensure high patient safety and comfort
- Used in over 100 academic and clinical research sites worldwide